Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Current ratio | 1.59 | 1.52 | 1.62 | 1.77 | 1.82 | |
| Quick ratio | 1.24 | 1.20 | 1.20 | 1.37 | 1.47 | |
| Cash ratio | 1.13 | 1.10 | 1.08 | 1.29 | 1.37 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
Liquidity metrics experienced a gradual decline between 2019 and 2022, with a marginal upward correction occurring in 2023. Throughout this five-year period, the organization maintained a liquidity position where current assets consistently exceeded current liabilities, suggesting a stable short-term financial posture.
- Current Ratio Trends
- A consistent reduction is observed from 2019, where the ratio stood at 1.82, reaching a minimum of 1.52 in 2022. The subsequent increase to 1.59 in 2023 indicates a reversal of the previous downward trend, though the ratio remains below its 2019 peak.
- Quick Ratio Trends
- The quick ratio mirrored the movement of the current ratio, descending from 1.47 in 2019 to 1.20 in 2021 and 2022. A slight recovery to 1.24 was recorded in 2023. The limited variance between the current and quick ratios suggests that liquidity is not heavily dependent on inventory or other less liquid current assets.
- Cash Ratio Trends
- The cash ratio declined from 1.37 in 2019 to 1.08 in 2021. Stability was observed thereafter, with a slight increase to 1.13 by December 31, 2023. Because this ratio remained above 1.0 throughout the analyzed period, it is evident that cash and cash equivalents were sufficient to satisfy all short-term liabilities without relying on the liquidation of other current assets.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Current Ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Current assets | 29,986) | 26,183) | 24,893) | 23,641) | 19,888) | |
| Current liabilities | 18,872) | 17,178) | 15,331) | 13,394) | 10,929) | |
| Liquidity Ratio | ||||||
| Current ratio1 | 1.59 | 1.52 | 1.62 | 1.77 | 1.82 | |
| Benchmarks | ||||||
| Current Ratio, Competitors2 | ||||||
| Abbott Laboratories | 1.64 | 1.63 | 1.85 | — | — | |
| Elevance Health Inc. | 1.44 | 1.40 | 1.47 | — | — | |
| Intuitive Surgical Inc. | 4.76 | 4.40 | 5.08 | — | — | |
| Medtronic PLC | 2.39 | 1.86 | 2.65 | — | — | |
| UnitedHealth Group Inc. | 0.79 | 0.77 | 0.79 | — | — | |
| Current Ratio, Sector | ||||||
| Health Care Equipment & Services | 1.15 | 1.13 | 1.22 | — | — | |
| Current Ratio, Industry | ||||||
| Health Care | 1.23 | 1.23 | 1.31 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Current ratio = Current assets ÷ Current liabilities
= 29,986 ÷ 18,872 = 1.59
2 Click competitor name to see calculations.
A consistent increase in both current assets and current liabilities is observed between 2019 and 2023. While both metrics expanded over the five-year period, the rate of growth for short-term obligations exceeded that of liquid assets for the majority of the timeframe, resulting in a general compression of the liquidity margin until a slight recovery in the final year.
- Current Assets Trend
- Total current assets demonstrated steady growth, rising from 19,888 million US$ in 2019 to 29,986 million US$ in 2023. The most significant acceleration in asset accumulation occurred between 2022 and 2023, where assets increased by approximately 3,803 million US$.
- Current Liabilities Trend
- Current liabilities followed a similar upward trajectory, increasing from 10,929 million US$ in 2019 to 18,872 million US$ in 2023. This represents a consistent rise in short-term obligations over the period analyzed.
- Current Ratio Analysis
- The current ratio experienced a downward trend from 1.82 in 2019 to a period low of 1.52 in 2022. This decline indicates that liabilities grew at a faster proportional rate than assets during this interval. However, the trend reversed in 2023, with the ratio improving to 1.59, suggesting a strengthening of the short-term financial position. Despite the fluctuations, the ratio remained well above 1.0 throughout the entire period, confirming that the organization maintained sufficient current assets to cover its current liabilities.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Quick Ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Cash and cash equivalents | 4,694) | 5,061) | 3,394) | 4,673) | 4,054) | |
| Investment securities | 16,626) | 13,881) | 13,192) | 12,554) | 10,972) | |
| Receivables, net of allowances | 2,035) | 1,674) | 1,814) | 1,138) | 1,056) | |
| Total quick assets | 23,355) | 20,616) | 18,400) | 18,365) | 16,082) | |
| Current liabilities | 18,872) | 17,178) | 15,331) | 13,394) | 10,929) | |
| Liquidity Ratio | ||||||
| Quick ratio1 | 1.24 | 1.20 | 1.20 | 1.37 | 1.47 | |
| Benchmarks | ||||||
| Quick Ratio, Competitors2 | ||||||
| Abbott Laboratories | 1.00 | 1.06 | 1.28 | — | — | |
| Elevance Health Inc. | 1.30 | 1.27 | 1.33 | — | — | |
| Intuitive Surgical Inc. | 3.83 | 3.56 | 4.34 | — | — | |
| Medtronic PLC | 1.54 | 1.30 | 1.91 | — | — | |
| UnitedHealth Group Inc. | 0.73 | 0.70 | 0.72 | — | — | |
| Quick Ratio, Sector | ||||||
| Health Care Equipment & Services | 0.97 | 0.95 | 1.04 | — | — | |
| Quick Ratio, Industry | ||||||
| Health Care | 0.90 | 0.93 | 1.00 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 23,355 ÷ 18,872 = 1.24
2 Click competitor name to see calculations.
The liquidity position from 2019 to 2023 is characterized by a simultaneous increase in liquid assets and short-term obligations, leading to an initial decline in the quick ratio followed by a period of stabilization and slight recovery.
- Total Quick Assets
- A consistent upward trend is observed in total quick assets, which grew from US$ 16,082 million in 2019 to US$ 23,355 million in 2023. This steady increase indicates a continuous expansion of the most liquid resources available to meet short-term requirements.
- Current Liabilities
- Current liabilities experienced significant growth over the five-year period, rising from US$ 10,929 million in 2019 to US$ 18,872 million in 2023. The pace of growth for liabilities exceeded that of quick assets between 2019 and 2021, which exerted downward pressure on the liquidity ratio.
- Quick Ratio Trends
- The quick ratio declined from 1.47 in 2019 to 1.20 in 2021, remaining stagnant at 1.20 through 2022 before increasing slightly to 1.24 in 2023. Despite this volatility, the ratio remained consistently above 1.0 throughout the period, signifying that the organization maintained sufficient liquid assets to cover its current liabilities without relying on the sale of inventory.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Cash Ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Cash and cash equivalents | 4,694) | 5,061) | 3,394) | 4,673) | 4,054) | |
| Investment securities | 16,626) | 13,881) | 13,192) | 12,554) | 10,972) | |
| Total cash assets | 21,320) | 18,942) | 16,586) | 17,227) | 15,026) | |
| Current liabilities | 18,872) | 17,178) | 15,331) | 13,394) | 10,929) | |
| Liquidity Ratio | ||||||
| Cash ratio1 | 1.13 | 1.10 | 1.08 | 1.29 | 1.37 | |
| Benchmarks | ||||||
| Cash Ratio, Competitors2 | ||||||
| Abbott Laboratories | 0.53 | 0.66 | 0.78 | — | — | |
| Elevance Health Inc. | 0.87 | 0.86 | 0.95 | — | — | |
| Intuitive Surgical Inc. | 3.15 | 2.90 | 3.66 | — | — | |
| Medtronic PLC | 0.88 | 0.85 | 1.27 | — | — | |
| UnitedHealth Group Inc. | 0.34 | 0.36 | 0.36 | — | — | |
| Cash Ratio, Sector | ||||||
| Health Care Equipment & Services | 0.55 | 0.58 | 0.64 | — | — | |
| Cash Ratio, Industry | ||||||
| Health Care | 0.50 | 0.54 | 0.60 | — | — | |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 2023 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 21,320 ÷ 18,872 = 1.13
2 Click competitor name to see calculations.
Between 2019 and 2023, a simultaneous increase in total cash assets and current liabilities was observed. Total cash assets grew from 15,026 million US$ to 21,320 million US$, while current liabilities rose from 10,929 million US$ to 18,872 million US$. Although both metrics trended upward, the growth in liabilities occurred at a faster relative pace than the accumulation of cash during the first half of the period.
- Cash Ratio Trend
- A declining trend in the cash ratio is evident from 2019 to 2021, where the ratio fell from 1.37 to 1.08. This decline indicates that current liabilities expanded more rapidly than the cash reserves available to cover them during this timeframe.
- Recent Liquidity Stabilization
- Following the low in 2021, the cash ratio exhibited a gradual recovery, increasing to 1.10 in 2022 and 1.13 in 2023. This suggests a recent realignment and a strengthening of the relationship between cash holdings and short-term obligations.
- Immediate Solvency Analysis
- The cash ratio remained consistently above 1.0 throughout the entire five-year period. This indicates a robust immediate liquidity position, as the organization maintains sufficient cash assets to satisfy all current liabilities without relying on the sale of other current assets or accessing additional financing.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?